Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: May 19, 2023
Date Accepted: Jul 31, 2023

The final, peer-reviewed published version of this preprint can be found here:

Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study

Jenciūtė G, Kasputytė G, Bunevičienė I, Korobeinikova E, Vaitiekus D, Inčiūra A, Jaruševičius L, Bunevičius R, Krikštolaitis R, Krilavičius T, Juozaitytė E, Bunevičius A

Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study

JMIR Res Protoc 2023;12:e49096

DOI: 10.2196/49096

PMID: 37815850

PMCID: 10599285

Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients with Cancer: a Protocol for the Observational Study

  • Gabrielė Jenciūtė; 
  • Gabrielė Kasputytė; 
  • Inesa Bunevičienė; 
  • Erika Korobeinikova; 
  • Domas Vaitiekus; 
  • Arturas Inčiūra; 
  • Laimonas Jaruševičius; 
  • Romas Bunevičius; 
  • Ričardas Krikštolaitis; 
  • Tomas Krilavičius; 
  • Elona Juozaitytė; 
  • Adomas Bunevičius

ABSTRACT

Background:

Timely recognition of cancer progression and treatment complications is important for treatment guidance. Digital phenotyping is a promising method for precise and remote monitoring of patients in their natural environments using passively generated data from sensors of personal wearable devices.

Objective:

To evaluate whether passively generated data from smartphone sensors is feasible for remote monitoring of cancer patients to predict their disease trajectories and patient-centered health outcomes.

Methods:

We will recruit 200 patients undergoing treatment for cancer. Patients will be followed for six months. Passively generated data by sensors of personal smartphone devices will be continuously collected using the developed LAIMA smartphone application. Every two weeks patients will be asked to complete questionnaires pertaining to quality of life via smartphone application. Two visits will take place at months 1-3 and 3-6. We will examine the association between digital, clinical, and patient-reported health outcomes aiming to develop prediction models of clinically meaningful outcomes.

Results:

The study results will be published in peer-reviewed journals.

Conclusions:

The study will provide in-depth insight into temporally and spatially precise trajectories of cancer patients that will provide with novel digital health approach and will inform design of future interventional clinical trials in oncology.


 Citation

Please cite as:

Jenciūtė G, Kasputytė G, Bunevičienė I, Korobeinikova E, Vaitiekus D, Inčiūra A, Jaruševičius L, Bunevičius R, Krikštolaitis R, Krilavičius T, Juozaitytė E, Bunevičius A

Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study

JMIR Res Protoc 2023;12:e49096

DOI: 10.2196/49096

PMID: 37815850

PMCID: 10599285

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.